Cellular sublocalization of Cx43 and the establishment of functional coupling in IMR-32 neuroblastoma cells

Molecular Carcinogenesis

Volumn 42, Issue 3, 2005, Pages 159-169

  Arnold, Jennifer M ^a,b   Phipps, Mikael W ^a   Chen, Jiahua ^a   Phipps, Jenny ^a  

^a NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^b PharmaGap   (Canada)

Author keywords

Gap junction; PKA; PKC

Indexed keywords

8 BROMO CYCLIC AMP; CONNEXIN 43; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; CYCLIC AMP DERIVATIVE; FORSKOLIN; SERINE;

ARTICLE; CARCINOGENICITY; CELL COMMUNICATION; CELL MEMBRANE; CELL NUCLEUS; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CHILDHOOD CANCER; CONTROLLED STUDY; FLOW CYTOMETRY; GAP JUNCTION; GROWTH REGULATION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; NEUROBLASTOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SOLID TUMOR; TUMOR DIFFERENTIATION; WESTERN BLOTTING;

8-BROMO CYCLIC ADENOSINE MONOPHOSPHATE; BREFELDIN A; CELL COMMUNICATION; CELL LINE, TUMOR; CELL MEMBRANE; CELL NUCLEUS; CELL PROLIFERATION; CONNEXIN 43; CYCLIC AMP-DEPENDENT PROTEIN KINASES; CYCLOHEXIMIDE; DACTINOMYCIN; FORSKOLIN; GAP JUNCTIONS; HUMANS; NEUROBLASTOMA; PHOSPHORYLATION; PROTEIN BIOSYNTHESIS; PROTEIN TRANSPORT;

EID: 13944274566     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/mc.20072     Document Type: Article

References (74)

1. Beierle EA, Dai W, Langham MR, Chen MK. Neuroblastoma, apoptosis, and growth factors. Am Surg 2003;69:28-31.
2. Izbicki T, Mazur J, Izbicka E. Epidemiology and etiology of neuroblastoma: An overview. Anticancer Res 2003;23:755-760.
3. Schor NF. Neuroblastoma as a neurobiological disease. J Neurooncol 1999;41:159-166.
4. Shimada H, Ambros IM, Dehner LP, et al. The international neuroblastoma pathology classification (the Shimada system). Cancer 1999;86:364-372.
5. Brodeur GM. Neuroblastoma: Biological insights into a clinical enigma. Nat Rev Cancer 2003;3:203-216.
6. Maris JM, Weiss MJ, Mosse Y. Evidence for a hereditary neuroblastoma predisposition locus at chromosome 16p12-13. Cancer Res 2002;62:6651-6658.
7. Prasad KN, Cole WC, Yan XD, et al. Defects in cAMP-pathway may initiate carcinogenesis in dividing nerve cells: A review. Apoptosis 2003;8:579-586.
8. Rao RR, Kisaalita WS. Biochemical and electrophysiological differentiation profile of a human neuroblastoma (IMR-32) cell line. In Vitro Cell Dev Biol Anim 2002;38:450-456.
9. Voigt A, Zintl F. Effects of retinoic acid on proliferation, apoptosis, cytotoxicity, migration, and invasion of neuroblastoma cells. Med Pediatr Oncol 2003;40:205-213.
10. Wainwright LJ, Lasorella A, Iavarone A. Distinct mechanisms of cell-cycle arrest control the decision between differentiation and senescence in human neuroblastoma cells. PNAS 2001;98:9396-9400.
11. Eggert A, Ilkegaki N, Liu XG, Chou TT, Brodeur GM. TrkA signal transduction pathways in neuroblastoma. Med Pediatr Oncol 2001;36:108-110.
12. Eggert A, Grotzer MA, Ilkegaki N, Liu XG, Evans AE, Brodeur GM. Expression of the neurotrophin receptor TrkA down regulates expression and function of angiogenic stimulators in SH-SY5Y neuroblastoma cells. Cancer Res 2002;62:1802-1808.
13. Ho R, Eggert A, Hishiki T, et al. Resistance to chemotherapy mediated by TrkB in neuroblastomas. Cancer Res 2002;62: 6462-6466.
14. Nakagawara A. Trk receptor tyrosine kinases: A bridge between cancer and neural development. Cancer Lett 2001; 169:107-114.
15. Chipman JK, Mally A, Edwards GO. Disruption of gap junctions in toxicity and carcinogenicity. Toxicol Sci 2003; 71:146-153.
16. George CH, Kendall JM, Evans WH. Intracellular trafficking pathways in the assembly of connexins into gap junctions. J Biol Chem 1999;274:8678-8685.
17. Laing JG, Tadros PN, Westphale EM, Beyer EC. Degradation of connexin43 gap junctions involves both the proteasome and the lysosome. Exp Cell Res 1997;236:482-492.
18. Laird DW, Castillo M, Kasprzak L. Gap junction turnover, intracellular trafficking, and phosphorylation of connexin43 in brefeldin A-treated rat mammary tumour cells. J Cell Biol 1995;131:1193-1203.
19. Lauf U, Giepmans BNG, Lopez P, Braconnot S, Chen SC, Falk MM. Dynamic trafficking and delivery of connexons to the plasma membrane and accretion to gap junctions in living cells. PNAS 2002;99:10446-10451.
20. Evans WH, Martin PE. Gap junctions: Structure and function. Mol Membr Biol 2002;19:121-136.
21. Lin JHC, Yang J, Liu S. Connexin mediates gap junction-independent resistance to cellular injury. J Neurosci 2003;23: 430-441.
22. Perez Velazquez JL, Frantseva MV, Naus CCG. Gap junctions and neuronal injury: Protectants or executioners? Neuroscientist 2003;9:5-9.
23. Bruzzone R, White TW, Paul DL. Connections with connexins: The molecular basis of direct intercellular signaling. Eur J Biochem 1996;238:1-27.
24. Loewenstein WR, Rose BR. The cell-cell channel in the control of growth. Cell Biol 1992;3:59-79.
25. v-src-transformed cells. Biochem J 1993;295: 735-742.
26. Mesnil M. Connexins and cancer. Biol Cell 2002;94:493-500.
27. Carystinos GD, Katabi MM, Laird DW, et al. 1999. Cyclic-AMP induction of gap junction intercellular communication increases bystander effect in suicide gene therapy. Clin Cancer Res 1999;5:61-68.
28. Carystinos GD, Alaoui-Jamali MA, Phipps J, Yen L, Batist G. Upregulation of gap junctional intercellular communication and connexin 43 expression by cyclic-AMP and all-trans-retinoic acid is associated with glutathione depletion and chemosensitivity in neuroblastoma cells. Cancer Chemother Pharmacol 2001;47:126-132.
29. Trosko JE, Ruch RJ. Gap junctions as targets for cancer chemoprevention and chemotherapy. Curr Drug Targets 2002;3:1-17.
30. Trosko JE, Ruch RJ. Cell-cell communication in carcinogenesis. Front Biosci 1998;3:208-236.
31. Yamasaki H, Krutovskikh V, Mesnil M, Tanaka T, Zaidan-Dagli ML, Omori Y. Role of connexin (gap junction) genes in cell growth control and cardnogenesis. Life Sci 1999;322: 151-159.
32. Yamasaki H. Aberrant expression and function of gap junctions during carcinogenesis. Environ Health Perspect 1991;93:191-197.
33. Huang RP, Fan Y, Hossain MZ, Peng A, Zeng ZL, Boynton AL. Reversion of the neoplastic phenotype of human glioblastoma by connexin 43. Cancer Res 1998;58:5089-5096.
34. Huang R, Liu YG, Fan Y, Boynton A, Yang D, Huang RP. Enhanced apoptosis under low serum conditions in human glioblastoma cells by connexin 43 (Cx43). Mol Carcinog 2001;32:128-138.
35. Matesic DF, Rupp HL, Bonney WJ, Ruch RJ, Trosko JE. Changes in gap-junction permeability, phosphorylation, and number mediated by phorbol ester and non-phorbol-ester tumor promoters in rat liver epithelial cells. Mol Carcinog 1994;10:226-236.
36. Soroceanu L, Manning T, Sontheimer H. Reduced expression of connexin-43 and functional gap junction coupling in human gliomas. Glia 2001;33:107-117.
37. Krutovskikh VA, Troyanovsky SM, Piccoli C, Tsuda H, Asamoto M, Yamasaki H. Differential effect of subcellular localization of communication impairing gap junction protein connexin43 on tumour cell growth in vivo. Oncogene 2000;19:505-513.
38. Mao AJ, Bechberger J, Lidington D, Galipeau J, Laird DW, Naus CCG. Neuronal differentiation and growth control of Neuro-2a cells after retroviral gene delivery of connexin43. J Biol Chem 2000;275:34407-34414.
39. Rose B, Mehta PP, Loewenstein WR. Gap junction protein gene suppresses tumorigenicity. Carcinogenesis 1993;14: 1073-1075.
40. Sanchez-Alvarez R, Tabernero A, Sanchez-Abarca LI, Orfao A, Giaume C, Medina JM. Proliferation of C6 glioma cells is blunted by the increase in gap junction communication caused by tolbutamide. FEBS Lett 2001;509:202-206.
41. Vine AL, Bertram JS. Cancer chemoprevention by connexins. Cancer Metastasis Rev 2002;21:199-216.
42. Dowling-Warriner CV, Trosko JE. Induction of gap junctional intercellular communication, connexin43 expression, and subsequent differentiation in human fetal neuronal cells by stimulation of the cyclic AMP pathway. Neuroscience 2000;95:859-868.
43. Matesic DF, Hayashi T, Trosko JE, Germak JA. Upregulation of gap junctional intercellular communication in immortalized gonadotropin-releasing hormone neurons by stimulation of the cyclic AMP pathway. Neuro-endocr 1996;64: 286-297.
44. Wynn J, Shah U, Murray SA. Redistribution of connexin 43 by cAMP: A mechanism for growth control in adrenal cells. Endocrinol Res 2002;28:663-668.
45. El Fouly MH, Trosko JE, Chang CC. Scrape-loading and dye transfer. A rapid and simple technique to study gap junctional intercellular communication. Exp Cell Res 1987;168: 422-430.
46. Shah MM, Martinez AM, Fletcher WH. The connexin 43 gap junction protein is phosphorylated by protein kinase A and protein kinase C: In vivo and in vitro studies. Mol Cell Biochem 2002;238:57-68.
47. Yogo K, Ogawa T, Akiyama M, Ishida N, Takeya T. Identification and functional analysis of novel phosphorylation sites in Cx43 in rat primary granulosa cells. FEBS Lett 2002; 531:132-136.
48. Nahreini P, Andreatta C, Prasad KN. Proteasome activity is critical for the cAMP-induced differentiation of neuroblastoma cells. Cell Mol Neurobiol 2001;21:509-521.
49. Sasaki K, Maruyama K, Nishimura E, Tsukada T, Yamaguchi K. Differentiation of cultured neuroblastoma induced by staurosporine and cyclic AMP: Methods for assessing neuronal phenotype. Brain Res Brain Res Prot 1997;1:399-405.
50. Wu G, Fang Y, Lu ZH, Ledeen RW. Induction of axon-like and dendrite-like processes in neuroblastoma cells. J Neurocytol 1998;27:1-14.
51. Banoub RW, Fernstrom M, Malkinson AM, Ruch RJ. Enhancement of gap junctional intercellular communication by dibutyryl cyclic AMP in lung epithelial cells. Anticancer Res 1996;16:3715-3719.
52. Cruciani V, Mikalsen SO. Stimulated phosphorylation of intracellular connexin43. Exp Cell Res 1999;251:285-298.
53. Leykauf K, Durst M, Alonso A. Phosphorylation and subcellular distribution of connexin 43 in normal and stressed cells. Cell Tissue Res 2003;311:23-30.
54. Cruciani V, Mikalsen SO. Connexins, gap junctional intercellular communication and kinases. Biol Cell 2002;94:433-443.
55. Rivedal E, Opsahl H. Role of PKC and MAP kinase in EGT and TPA induced connexin 43 phosphorylation and inhibition of gap junction intercellular communication in rat liver epithelial cells. Carcinogenesis 2001;22:1543-1550.
56. Lampe PD, Lau AF. Regulation of gap junctions by phosphorylation of connexins. Arch Biochem Biophys 2000;384: 205-215.
57. Vanslyke JK, Musil LS. Degradation of connexins from the plasma membrane is regulated by inhibitors of protein synthesis. Cell Comm Adhes 2003;10:329-333.
58. Abudara V, Garces G, Saez JC. Cells of the carotid body express connexin43 which is upregulated by cAMP. Brain Res 1999;849:25-33.
59. Kralik P, Vitek JA. Effect of drugs affecting synthesis or degradation of connexin on onset or completion of ethylene glycol induced inhibition of intercellular gap junctional communication. Neoplasma 2002;49:290-294.
60. TenBroek EM, Lampe PD, Solan JL, Reynhout JK, Johnson RG. Ser364 of connexin 43 and the upregulation of gap junction assembly by cAMP. J Cell Biol 2001;155:1307-1318.
61. Hossain MZ, Boynton AL. Regulation of Cx43 gap junctions: The gatekeeper and the password. Sci STKE 2000;54:1-5.
62. Musil LS, Goodenough DA. Biochemical analysis of connexin43 intracellular transport, phosphorylation, and assembly into gap junctional plaques. J Cell Biol 1991;115: 1357-1374.
63. Cottrell GT, Lin R, Warn-Cramer BJ, Lau AF, Burt JM. Mechanism of v-Src and mitogen-activated protein kinase-induced reduction of gap junction communication. Am J Cell Physiol 2003;284:C511-C520.
64. Cho-Chung YS, Nesterova M, Becker KG, et al. Dissecting the circuitry of protein kinase A and cAMP signalling in cancer genesis. Ann NY Acad Sci 2002;968:22-36.
65. Yokozaki H, Tortora G, Pepe S, et al. Unhydrolyzable analogues of adenosine 3′:5′-monophosphate demonstrating growth inhibition and differentiation in human cancer cells. Cancer Res 1992;52:2504-2508.
66. Doble BW, Dang X, Ping P, et al. Phosphorylation of serine 262 in the gap junction protein connexin 43 regulates DNA synthesis in cell-cell contact forming cardiomyocytes. J Cell Sci 2004;117:507-514.
67. Phipps M, Phipps J, Whitfield JF, Ally A, Somorjai RL, Narang SA. Carcinogenic implications of the neighbourhood coherence principle (NCP). Med Hypotheses 1990;31:289-301.
68. Phipps M, Darozewski J, Phipps J. 1997. How the neighbourhood coherence principle (NCP) can give rise to tissue homeostasis: A cellular automaton approach. J Theor Biol 1997;185:475-487.
69. Budunova IV, Carbajal S, Viaje A, Slaga TJ. Connexin expression in epidermal cell lines from SENCAR mouse skin tumors. Mol Carcinog 1996;15:190-201.
70. Carruba G, Webber MM, Quader ST, et al. Regulation of cell to cell communication in non-tumourigenic and malignant human prostate epithelial cells. Prostate 2002;50: 73-82.
71. De Feijter AW, Matesic DF, Ruch RJ, Guan X, Chang CC, Trosko JE. Localization and function of the connexin 43 gap-junction protein in normal and various oncogene-expressing rat liver epithelial cells. Mol Carcinog 1996;16:203-212.
72. Hanna EA, Umhauer S, Roshong SL, et al. Gap junctional intercellular communication and connexin 43 expression in human ovarian surface epithelial cells and ovarian carcinomas in vivo and in vitro. Carcinogenesis 1999;20: 1369-1373.
73. Oyamada Y, Oyamada M, Fusco A, Yamasaki Y. Aberrant expression, function, and localization of connexins in human esophageal carcinoma cell lines with different degrees of tumorigenicity. J Cancer Res Clin Oncol 1994;120:445-453.
74. Tai MH, Olson LK, Madhukar BV, et al. Characterization of gap junction intercellular communication in immortalized human pancreatic ductal epithelial cells with stem cell characteristics. Pancreas 2003;26:18-26.